First SGLT1/2 inhibitor shows ‘spectacular’ phase 3 safety and efficacy in T2DNovember 18, 2020DiabetesCardiology
Lancet panel calls for urgent global action to combat diabetesNovember 13, 2020DiabetesBusiness of Medicine
Medication adherence challenges and helpersNovember 6, 2020Business of MedicinePulmonologyWomen's HealthDiabetes
Evaluation of Metabolic Monitoring and Diabetes Incidence in the First Year for Veterans Newly Started on an Atypical AntipsychoticNovember 6, 2020Diabetes
Novel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesStrokeNephrologyCardiologyMixed Topics
COVID-19 antibody response not reduced with diabetesOctober 20, 2020DiabetesCOVID-19 UpdatesInfectious Diseases
T2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesCardiology
